Exelixis (EXEL) reported Q3 non-GAAP net income late Tuesday of $0.78 per diluted share, up from $0.47 a year earlier.

Analysts polled by FactSet expected $0.69.

Revenue in the three months ended Sept. 30 rose to $597.8 million from $539.5 million a year earlier.

Analysts polled by FactSet expected $590.2 million.

The company expects full-year revenue of $2.3 billion to $2.35 billion, compared with the prior estimate of $2.25 billion to $2.35 billion.

Analysts polled by FactSet project $2.32 billion.